Latest News
In this section you will find the latest Bayer Schering Pharma press releases for the United Kingdom.
If you have a particular enquiry about any of these releases then please contact us on the telephone number or e-mail address below:-
Tel: 01635 563198
E-mail: bsp-communications@bayerhealthcare.com
Bayer’s Novel Oral Anticoagulant Xarelto®(rivaroxaban) Gets European Licence
3rd October2008
New drug Xarelto® (rivaroxaban), which has been shown to be significantly more effective than current standard, gets UK licence>>more
Bayer’s Novel Anticoagulant Rivaroxaban Recommended for Approval in the EU
25th July 2008
Venous blood clot prevention after elective hip or knee replacement surgery - Final approval from the European Commission expected within the next few months..>>more
Doctor in the House - TV’s Doctor Christian Jessen visits Bayer
18th June 2008
TV celebrity, Dr. Christian Jessen, star of Channel 4’s ‘Embarrassing Illnesses’ and ‘Supersize vs Superskinny’ was at Bayer's Newbury headquarters this week to talk to staff about men's health issues.>>
more
Rivaroxaban First Oral Anticoagulant to Show Superiority to Enoxaparin 30mg twice-daily in Preventing Blood Clots After Knee Replacement Surgery
30th May 2008
New head-to-head Phase III data confirm oral anticoagulant rivaroxaban is significantly more effective than twice-daily injections ofenoxaparin in preventing life threatening blood clots after total knee replacement surgery.>>
more